July 08, 2026
The Science Behind Akkermansia and Gut Barrier Integrity
How Akkermansia muciniphila relates to gut barrier integrity and the mucus layer—strain-specific evidence and responsible claims. Request the AKK PROBIO doss...
Read moreAKK updates
AKK PROBIO Updates & Insights
Company news, event updates, and technical explainers for teams following Akkermansia ingredient development.
July 08, 2026
Formulating with Akkermansia: Stability, Shelf Life, Dosage, and AFU / TFU Specifications
A B2B formulation guide to Akkermansia—form selection, stability, shelf life, and AFU/TFU dose units. Request the AKK PROBIO specifications and dossier.
Read moreJuly 08, 2026
Akkermansia Regulatory Status in the U.S.: GRAS, NDI, and 21 CFR Considerations
Akkermansia in the U.S.—GRAS, NDI #1468, and 21 CFR 170.30 explained by strain and form, with claim guardrails. Request the AKK PROBIO regulatory dossier.
Read moreJuly 08, 2026
Postbiotics vs. Probiotics: Why Pasteurized Akkermansia Matters
Live vs pasteurized Akkermansia—probiotic vs postbiotic, stability, dose units, and regulatory differences for B2B formulation. Request the AKK PROBIO dossier.
Read moreJuly 08, 2026
How Akkermansia Strains Differ: A Supplier Comparison
Compare Akkermansia suppliers by strain, form, evidence, and regulatory status—not the species name. See where AKK PROBIO fits and request the dossier.
Read moreJuly 08, 2026
FDA NDI Notification for Akkermansia: What Brands Need to Know
What FDA NDI Notification #1468 means for Akkermansia—form-specific status, NDI vs GRAS, and what it is not. Request the AKK PROBIO regulatory dossier.
Read moreJuly 08, 2026
Akkermansia and Weight Management: What Human RCT Data Means for B2B Formulation
What Akkermansia human RCT evidence means for B2B weight-management formulation—strain, form, dose, and responsible claims. Request the AKK PROBIO dossier.
Read moreJuly 08, 2026
Where to Source Akkermansia for Private Label and Contract Manufacturing Projects
A B2B sourcing guide to Akkermansia for private label and contract manufacturing—strain, form, dossier, and regulatory fit. Request the AKK PROBIO dossier.
Read moreJuly 08, 2026
How to Evaluate Akkermansia Ingredient Suppliers: A B2B Procurement Guide
A B2B procurement guide to evaluating Akkermansia suppliers by strain, form, GRAS/NDI status, evidence, and stability. Request the AKK PROBIO dossier.
Read moreMay 30, 2026
Live vs. Pasteurized Akkermansia muciniphila: Which Form Fits Your Formulation?
Akkermansia muciniphila is one of the most researched next-generation probiotics, and for product developers it comes in two forms: live (probiotic) and past...
Read more